BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34147364)

  • 21. Rapid Implementation of a Community-Academic Partnership Model to Promote COVID-19 Vaccine Equity within Racially and Ethnically Minoritized Communities.
    Abdul-Mutakabbir JC; Granillo C; Peteet B; Dubov A; Montgomery SB; Hutchinson J; Casey S; Simmons K; Fajardo A; Belliard JC
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health Center Testing for SARS-CoV-2 During the COVID-19 Pandemic - United States, June 5-October 2, 2020.
    Romero L; Pao LZ; Clark H; Riley C; Merali S; Park M; Eggers C; Campbell S; Bui C; Bolton J; Le X; Fanfair RN; Rose M; Hinckley A; Siza C
    MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1895-1901. PubMed ID: 33332299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RADx-UP Testing Core: Access to COVID-19 Diagnostics in Community-Engaged Research with Underserved Populations.
    Narayanasamy S; Veldman TH; Lee MJ; Glover WA; Tillekeratne LG; Neighbors CE; Harper B; Raghavan V; Kennedy SW; Carper M; Denny T; Tsalik EL; Reller ME; Kibbe WA; Corbie G; Cohen-Wolkowiez M; Woods CW; Petti CA
    J Clin Microbiol; 2023 Aug; 61(8):e0036723. PubMed ID: 37395655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The [underutilized] power of independent pharmacies to promote public health in rural communities: A call to action.
    Ashcraft AM; Ponte CD; Farjo S; Dotson S; Murray PJ
    J Am Pharm Assoc (2003); 2022; 62(1):38-41. PubMed ID: 34556429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No Populations Left Behind: Vaccine Hesitancy and Equitable Diffusion of Effective COVID-19 Vaccines.
    Webb Hooper M; Nápoles AM; Pérez-Stable EJ
    J Gen Intern Med; 2021 Jul; 36(7):2130-2133. PubMed ID: 33754319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid Transition to Telehealth and the Digital Divide: Implications for Primary Care Access and Equity in a Post-COVID Era.
    Chang JE; Lai AY; Gupta A; Nguyen AM; Berry CA; Shelley DR
    Milbank Q; 2021 Jun; 99(2):340-368. PubMed ID: 34075622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacist's Role and Pharmaceutical Care During the COVID-19 Pandemic.
    Amariles P; Ledezma-Morales M; Salazar-Ospina A; Hincapié-García JA
    Adv Exp Med Biol; 2021; 1318():605-622. PubMed ID: 33973201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diversity and inclusion in clinical trials: Evolution throughout the development of an mRNA COVID-19 vaccine.
    Hill J; Montross D; Ivarsson M
    Front Public Health; 2023; 11():1113003. PubMed ID: 37181705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Texas Community-Engagement Research Alliance Against COVID-19 in Disproportionately Affected Communities (TX CEAL) Consortium.
    Seguin-Fowler RA; Amos C; Beech BM; Ferrer RL; McNeill L; Opusunju JJ; Spence E; Thompson EL; Torres-Hostos LR; Vishwanatha JK
    J Clin Transl Sci; 2022; 6(1):e64. PubMed ID: 35720963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [THE NEED FOR REDUCING DISPARITIES IN SARS-COV-2 IMMUNIZATION: THE ULTRAORTHODOX AND ARAB POPULATIONS IN ISRAEL].
    Ber I; Lerman Y; Muhsen K
    Harefuah; 2021 May; 160(5):285-290. PubMed ID: 34028219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey.
    Tsai R; Hervey J; Hoffman K; Wood J; Johnson J; Deighton D; Clermont D; Loew B; Goldberg SL
    JMIR Public Health Surveill; 2022 Jan; 8(1):e29872. PubMed ID: 34709184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing COVID-19 testing strategies in K-12 schools in underserved populations: study protocol for a cluster-randomized trial.
    Hayes S; Malone S; Bonty B; Mueller N; Reyes SM; Reyes SA; Evans C; Wilcher-Roberts M; Watterson T; Akuse S; Shelley J; Yuan G; Lackey I; Prater J; Montgomery B; Williams C; Butler-Barnes ST; Harris K; Caburnay C; Dougherty NL; Liu J; Lai A; Neidich J; Fritz S; Newland JG
    BMC Public Health; 2022 Jun; 22(1):1177. PubMed ID: 35698094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacist-Led Chronic Care Management for Medically Underserved Rural Populations in Florida During the COVID-19 Pandemic.
    Como M; Carter CW; Larose-Pierre M; O'Dare K; Hall CR; Mobley J; Robertson G; Leonard J; Tew L
    Prev Chronic Dis; 2020 Jul; 17():E74. PubMed ID: 32730199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries.
    Paudyal V; Cadogan C; Fialová D; Henman MC; Hazen A; Okuyan B; Lutters M; Stewart D
    Res Social Adm Pharm; 2021 Aug; 17(8):1507-1517. PubMed ID: 33288420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innovative partnership in Connecticut to expand health professional eligibility to administer COVID-19 vaccines.
    Doyno CR; Fitzgerald JM; White CM; Sobieraj DM; Zacchera M
    J Am Pharm Assoc (2003); 2022; 62(1):247-252. PubMed ID: 34462216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.
    Malik JA; Ahmed S; Mir A; Shinde M; Bender O; Alshammari F; Ansari M; Anwar S
    J Infect Public Health; 2022 Feb; 15(2):228-240. PubMed ID: 35042059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Care Clinicians as COVID-19 Vaccine Ambassadors.
    Katzman JG; Katzman JW
    J Prim Care Community Health; 2021; 12():21501327211007026. PubMed ID: 33787395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacist-provided SARS-CoV-2 testing targeting a majority-Hispanic community during the early COVID-19 pandemic: Results of a patient perception survey.
    Patel J; Christofferson N; Goodlet KJ
    J Am Pharm Assoc (2003); 2022; 62(1):187-193. PubMed ID: 34465524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rebuilding public trust: a clarified response to COVID-19 vaccine hesitancy predicament.
    Cordero DA
    J Public Health (Oxf); 2021 Jun; 43(2):e303-e304. PubMed ID: 33539536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.